Skip to main content

UPDATE 1-Celgene in talks to buy Juno Therapeutics -WSJ

Jan 16 (Reuters) - Celgene Corp is in talks to buy Juno Therapeutics Inc, which is working on an experimental gene therapy drug to treat cancer, the Wall Street Journal reported on Tuesday, citing sources familiar with the matter. (http://on.wsj.com/2EMlysO)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.